Nephrolithiasis, the formation of kidney stones, is a common condition seen in up to 12 percent of adults during their lifetime. As the mechanisms by which stones form are poorly understood, new knowledge is required to identify susceptible patients for early treatment and to formulate new therapeutic strategies to prevent the appearance of single and/or recurrent stones. How nascent crystals that nucleate in tubular fluid are retained in the nephron and form calculi is not known. My studies during the past 8 years demonstrate that calcium oxalate monohydrate (COM) crystals bind within seconds to anionic, sialic acid- containing glycoproteins on the apical surface of cultured monkey kidney epithelial cells (BSC-1), employed to model the tubule, suggesting one mechanism whereby crystals could be retained in the kidney in vivo. Preliminary studies have identified constitutive release of a protein by BSC-1 cells that blocks adhesion of COM crystals to the apical cell surface; it has been named the Crystal Adhesion Inhibitor, or CAI. A novel method employing COM crystal affinity chromatography was used to purify CAI. Evidence provided in this revised application demonstrates that CAI is a constituent of normal human urine. Biochemical characterization identifies it as a sialic acid-containing glycoprotein. Microsequencing of the amino terminus and 9 fragments generated by lys-C and asp-N protease cleavage reveal that CAI is novel. Two monospecific antibodies against synthetic peptides prepared using amino acid sequence information each recognize the factor on Western blots of partially- purified normal human urine, renal cell conditioned medium, and total kidney cell protein. The goal of this revised research plan is to define the potential role of CAI in human nephrolithiasis.
New Specific Aims are to: 1) Utilize 2 monospecific antibodies prepared against CAI to characterize and quantitate it in the urine of normal and stone- forming individuals; 2) Study inhibition of COM, hydroxyapatite, and uric acid crystal adhesion to renal cells by CAI isolated from conditioned medium and the urine of normal and stone-forming subjects; 3) Study inhibition of COM crystal growth by CAI isolated from conditioned medium and the urine of normal and stone-forming subjects, 4) Study inhibition of COM crystal aggregation by CAI isolated from conditioned medium and the urine of normal and stone-forming individuals, 5) Utilize the monospecific antibodies prepared against CAI to isolate affinity-purified protein and study its physical-chemical properties; 6) Study the cell biology of CAI. Achieving these specific aims will provide new knowledge about mechanisms that mediate stone formation, and provide a rational basis for design of novel strategies to treat and/or prevent this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK053399-06S1
Application #
6736760
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Rasooly, Rebekah S
Project Start
1999-05-01
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2006-04-30
Support Year
6
Fiscal Year
2003
Total Cost
$187,111
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kim, Hidong; Zhen, David B; Lieske, John C et al. (2014) Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy. J Med Cases 5:376-379
Lieske, John C; Regnier, Cynthia; Dillon, John J (2008) Use of sevelamer hydrochloride as an oxalate binder. J Urol 179:1407-10
Mo, Lan; Liaw, Lucy; Evan, Andrew P et al. (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol 293:F1935-43
Atmani, Fouad; Farell, Gerard; Lieske, John C (2004) Extract from Herniaria hirsuta coats calcium oxalate monohydrate crystals and blocks their adhesion to renal epithelial cells. J Urol 172:1510-4
Kumar, Vivek; Yu, Shihui; Farell, Gerard et al. (2004) Renal epithelial cells constitutively produce a protein that blocks adhesion of crystals to their surface. Am J Physiol Renal Physiol 287:F373-83
Lieske, John C; Farell, Gerard; Deganello, Sergio (2004) The effect of ions at the surface of calcium oxalate monohydrate crystals on cell-crystal interactions. Urol Res 32:117-23
Kumar, Vivek; Farell, Gerard; Deganello, Sergio et al. (2003) Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J Am Soc Nephrol 14:289-97
Kumar, Vivek; Farell, Gerard; Lieske, John C (2003) Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol 170:221-5
Lieske, J C; Toback, F G; Deganello, S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784-91
Lieske, J C; Toback, F G (2000) Renal cell-urinary crystal interactions. Curr Opin Nephrol Hypertens 9:349-55

Showing the most recent 10 out of 12 publications